Brian Murphy, MS, BS (he/him/his)

Beckman Coulter Life Sciences, Indiana, United States

Brian Murphy has been with Beckman Coulter Life Sciences since the aquisition of ValitaCell in June 2022. He is reposnisble for the commercial management of the ValitaCell portoflio of bionalytics, consisting of automatable bioanalytics assays and software. Brian has a background in biochemisty, biotechnology & process development, and has a passion for technologies that accelerate drug discovery & development workflows.

Disclosure information not submitted.

Presentation(s):

• 1. Putting the pieces together: adding efficiency to your synbio workflow through automation. 2. Streamlining cell line development processes with automated antibody analytics.

  Tuesday, February 6, 2024
  12:00 PM – 1:00 PM EST